Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA2DS2-VASc and GARFIELD-AF Risk Scores — José Miguel Rivera‐Caravaca (2020) | RDL Network
Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA2DS2-VASc and GARFIELD-AF Risk Scores
Article 2020 en
Authors
JR
José Miguel Rivera‐Caravaca
MP
Marco Proietti
ME
María Asunción Esteve‐Pastor
Abstract
1 min read
In a warfarin-treated trial cohort of AF patients, both CHA<sub>2</sub>DS<sub>2</sub>-VASc and GARFIELD-AF Stroke scores were associated with adjudicated TE events, with modest predictive capacity. The simpler CHA<sub>2</sub>DS<sub>2</sub>-VASc score improved discriminatory capacity compared with the more complex GARFIELD-AF score, demonstrating improved clinical usefulness and net clinical benefit.
Vanessa Roldán, José Miguel Rivera‐Caravaca, Alena Shantsila, Amaya García-Fernández, María Asunción Esteve‐Pastor, Juan A. Vílchez, Marta Romera, Mariano Valdés, Vicente Vicente, Francisco Marı́n, Professor Gregory Lip
Discussion(0)
No comments yet. Be the first to comment.